Alzamend Neuro Inc (NASDAQ: ALZN) on November 20, 2023, started off the session at the price of $1.71, plunging -17.75% from the previous trading day. During the day, the shares moved up to $1.92 and dropped to $1.14 before settling in for the closing price of $1.69. Within the past 52 weeks, ALZN’s price has moved between $1.32 and $19.80.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
The company achieved an average annual earnings per share of -13.33%. With a float of $3.26 million, this company’s outstanding shares have now reached $6.46 million.
Let’s determine the extent of company efficiency that accounts for 4 employees.
Alzamend Neuro Inc (ALZN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Alzamend Neuro Inc is 49.55%, while institutional ownership is 6.48%. The most recent insider transaction that took place on Sep 26, was worth 10,234. In this transaction Chief Financial Officer of this company bought 53,000 shares at a rate of $0.19, taking the stock ownership to the 81,000 shares. Before that another transaction happened on May 24, when Company’s 10% Owner bought 18,000 for $0.59, making the entire transaction worth $10,705. This insider now owns 383,000 shares in total.
Alzamend Neuro Inc (ALZN) Earnings and Forecasts
As on 7/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.6 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.52) by -$0.08. This company achieved a return on equity of -181.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.33% per share during the next fiscal year.
Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators
Alzamend Neuro Inc (ALZN) is currently performing well based on its current performance indicators. A quick ratio of 0.88 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.62 in one year’s time.
Technical Analysis of Alzamend Neuro Inc (ALZN)
Looking closely at Alzamend Neuro Inc (NASDAQ: ALZN), its last 5-days average volume was 0.95 million, which is a jump from its year-to-date volume of 36100.0. As of the previous 9 days, the stock’s Stochastic %D was 43.57%. Additionally, its Average True Range was 0.28.
During the past 100 days, Alzamend Neuro Inc’s (ALZN) raw stochastic average was set at 3.52%, which indicates a significant decrease from 29.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.50% in the past 14 days, which was higher than the 102.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7038, while its 200-day Moving Average is $6.3292. However, in the short run, Alzamend Neuro Inc’s stock first resistance to watch stands at $1.8267. Second resistance stands at $2.2633. The third major resistance level sits at $2.6067. If the price goes on to break the first support level at $1.0467, it is likely to go to the next support level at $0.7033. Should the price break the second support level, the third support level stands at $0.2667.
Alzamend Neuro Inc (NASDAQ: ALZN) Key Stats
Market capitalization of the company is 8.99 million based on 6,466K outstanding shares. Right now, sales total 0 K and income totals -14,880 K. The company made 0 K in profit during its latest quarter, and -3,530 K in sales during its previous quarter.